Donnez O, Jadoul P, Squifflet J, Donnez J. Unusual complication after uterine artery embolization and laparoscopic myomectomy in a woman wishing to preserve future fertility. Fertil Steril 2008; 90 (5): 5-9. IF: 4.167
Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL II Study Group (… Donnez O…) Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012 Feb 2;366(5):421-32. IF: 53.3
Marotta ML, Donnez J, Michaux N, Dupont M, Delos M, Donnez O. Spontaneous intramyometrial pregnancy mimicking an intra mural myoma : a diagnostic challenge. Gynecol Surg 2012; 9:439–444. IF: 0.4
Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser B, Barlow D, Palacios S, Donnez O, Bestel E, Osterloh I, Loumaye E, for the PEARL III and PEARL III Extension Study Group. Long-term treatment of uterine fibroids with ulipristal acetate . Fertil Steril 2014; 101 (61): 1565-1573 IF :4.695.
Donnez J, Donnez O, Dolmans MM. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertil Steril. 2014 ; 102: 640-8 IF :4.695.
Donnez J, Hudecek R, Donnez O, Matule D, Arhendt H, Zatik J, Kasilovskiene Z, Dumitrascu MC, Fernandez H, Barlow DH, Bouchard P, Fauser BC, Bestel E, Terrill P, Osterloh I, Loumaye E. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril. 2015 ; 103 :519-527 IF:4.426
Donnez J, Arrigada P, Donnez O, Dolmans M. Current management of myomas : The place of medical therapy with the advent of Selective Progesterone Receptor Modulators (SPRMs). Curr Opin Obstet Gynecol. 2015 Dec;27(6):422-31 IF: 2.134
Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik R, Zaneta Z, Kasilowskiene Z, Dumitrascu, Fernandez H, Barlow D, Bouchard P, Fauser BC, Bestel E, Loumaye E. Long-term medical management of uterine fibroids with Ulipristal Acetate. Fertil Steril. 2016 Jan;105(1):165-173 IF: 4.426
Donnez J, Donnez O, Courtoy GE, Dolmans MM. The place of selective progesterone modulators (SPRMs) in Myoma therapy. Minerva Med. 2016; 68:313-20. IF:0
Donnez J, Donnez O, Dolmans MM. Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. Expert Opinion on Drug Safety 2016 Dec;15(12):1679-1686. IF: 2.896
Donnez J, Donnez O, Dolmans MM. Rewriting the script: time to rethink the indications for myoma surgery. Fertil Steril 2017 Feb;107(2):334-335. IF: 4.426
Donnez J, Donnez O, Dolmans MM. The current place of medical therapy in uterine fibroid management. Best Pract Res Clin Obstet Gynaecol. 2017 Oct 22. pii: S1521-6934(17)30171-2.
Donnez J, Arriagada P, Donnez O, Dolmans MM. Emerging treatment options for uterine fibroids. Expert Opin Emerg Drugs. 2018 Mar;23(1):17-23.
Donnez J, Courtoy GE, Donnez O, Dolmans MM. Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review. Reprod Biomed Online. 2018 Aug;37(2):216-223.
Verguts J, Godin PA, De Vree B, Donnez O, Cosyns S, Luyckx M, Nisolle M. Effect on surgical decisions: ulipristal acetate as key player in Belgian phase IV registration trial. Int J Gynaecol Obstet. 2019 Dec;147(3):339-343